Literature DB >> 19296674

Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition.

Rommel A Mathias1, Bo Wang, Hong Ji, Eugene A Kapp, Robert L Moritz, Hong-Jian Zhu, Richard J Simpson.   

Abstract

Epithelial-mesenchymal transition (EMT) is a highly conserved morphogenetic process by which epithelial cells lose their basic morphological characteristics such as cell-cell contact and gain mesenchymal properties such as increased motility and invasiveness. To gain insights into proteins released from cells that modulate the EMT process, we compared secretome protein expression profiles of MDCK cells and Ras-transformed MDCK cells (21D1) that stably express oncogenic Ras using 2D-DIGE/LC-MS/MS. Differentially expressed secretome proteins were compared with their corresponding gene expression profiles using the Affymetrix GeneChip system. Down-regulated proteins were predominantly involved with cell-cell contact and cell-matrix adhesion (e.g., desmocollin 2, clusterin, collagen XVII and transforming growth factor-beta induced protein ig-h3), while up-regulated proteins were proteases and factors that promote migration (MMP-1, kallikrein 6, TIMP-1, and S100A4/metastasin). Many of the secretome proteins identified in this study have not been previously identified in the context of EMT and may shed light on the underlying mechanisms associated with this cellular process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296674     DOI: 10.1021/pr8010974

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  31 in total

1.  Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition.

Authors:  Yuan-Shou Chen; Rommel A Mathias; Suresh Mathivanan; Eugene A Kapp; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2010-05-28       Impact factor: 5.911

2.  HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.

Authors:  Simona di Martino; Carla Azzurra Amoreo; Barbara Nuvoli; Rossella Galati; Sabrina Strano; Francesco Facciolo; Gabriele Alessandrini; Harvey I Pass; Gennaro Ciliberto; Giovanni Blandino; Ruggero De Maria; Mario Cioce
Journal:  Oncogene       Date:  2018-01-09       Impact factor: 9.867

3.  CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.

Authors:  Guang-Xi Zhao; Ying-Ying Xu; Shu-Qiang Weng; Si Zhang; Ying Chen; Xi-Zhong Shen; Ling Dong; She Chen
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

4.  Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Authors:  Mark J Schliekelman; Don L Gibbons; Vitor M Faca; Chad J Creighton; Zain H Rizvi; Qing Zhang; Chee-Hong Wong; Hong Wang; Christin Ungewiss; Young-Ho Ahn; Dong-Hoon Shin; Jonathan M Kurie; Samir M Hanash
Journal:  Cancer Res       Date:  2011-10-10       Impact factor: 12.701

5.  SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.

Authors:  Manoj Kumar Kashyap; H C Harsha; Santosh Renuse; Harsh Pawar; Nandini A Sahasrabuddhe; Min-Sik Kim; Arivusudar Marimuthu; Shivakumar Keerthikumar; Babylakshmi Muthusamy; Kumaran Kandasamy; Yashwanth Subbannayya; Thottethodi Subrahmanya Keshava Prasad; Riaz Mahmood; Raghothama Chaerkady; Stephen J Meltzer; Rekha V Kumar; Anil K Rustgi; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

6.  Global secretome analysis identifies novel mediators of bone metastasis.

Authors:  Mario Andres Blanco; Gary LeRoy; Zia Khan; Maša Alečković; Barry M Zee; Benjamin A Garcia; Yibin Kang
Journal:  Cell Res       Date:  2012-06-12       Impact factor: 25.617

Review 7.  Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.

Authors:  George S Karagiannis; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-09-16       Impact factor: 6.603

Review 8.  Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.

Authors:  Claudia Palena; Duane H Hamilton; Romaine I Fernando
Journal:  Future Oncol       Date:  2012-06       Impact factor: 3.404

9.  Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).

Authors:  Frank He; Nora L Springer; Matthew A Whitman; Siddharth P Pathi; Yeonkyung Lee; Sunish Mohanan; Stephen Marcott; Aaron E Chiou; Bryant S Blank; Neil Iyengar; Patrick G Morris; Maxine Jochelson; Clifford A Hudis; Pragya Shah; Jennie A M R Kunitake; Lara A Estroff; Jan Lammerding; Claudia Fischbach
Journal:  Biomaterials       Date:  2019-09-11       Impact factor: 12.479

10.  Unconventional secretion is a major contributor of cancer cell line secretomes.

Authors:  Laura Villarreal; Olga Méndez; Cándida Salvans; Josep Gregori; José Baselga; Josep Villanueva
Journal:  Mol Cell Proteomics       Date:  2012-12-26       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.